Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical Device Innovation Consortium Sets Priorities To Advance Reg Science

This article was originally published in The Gray Sheet

Executive Summary

The heads of the newly formed private-public partnership comprising industry, academia and FDA describe the group’s top three projects to advance medical device regulatory science.

You may also be interested in...



People Briefs: CEO At LifeScience Alley; Orthofix, Exact Sciences Appoint Board Chairs

LifeScience Alley CEO Dale Wahlstrom retires and Shaye Mandle named successor. Orthofix International and Exact Sciences name new board chairs. Wound Management appoints new CFO, director of R&D and chief medical officer. Other people news.

FDA Steps Up Focus On Computational Modeling For Devices With Draft Guidance

The draft guidance outlines information on computational and simulation modeling studies that should be included in FDA device submissions. FDA has been encouraging companies to focus on modeling studies with a goal that they could eventually replace costly bench and animal studies.

FDA Steps Up Focus On Computational Modeling For Devices With Draft Guidance

The draft guidance outlines information on computational and simulation modeling studies that should be included in FDA device submissions. FDA has been encouraging companies to focus on modeling studies with a goal that they could eventually replace costly bench and animal studies.

Related Content

Topics

UsernamePublicRestriction

Register

MT031933

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel